Recombinant Human LTC4S Protein，His

LTC4S (leukotriene C4 synthase) is an important enzyme involved in the biosynthesis of leukotrienes, which are lipid mediators that play essential roles in various physiological and pathological processes, including inflammation, allergic responses, and asthma. The enzyme catalyzes the conversion of leukotriene A4 (LTA4) into leukotriene C4 (LTC4), a key component of the cysteinyl leukotrienes, which are implicated in bronchoconstriction and airway hyperreactivity. Research into LTC4S is particularly significant due to its potential as a therapeutic target for treating inflammatory diseases, including asthma and chronic obstructive pulmonary disease (COPD). The understanding of LTC4S structure, function, and regulation is crucial for developing specific inhibitors that can modulate its activity and, consequently, alleviate symptoms associated with leukotriene-mediated inflammatory responses. Recent studies have focused on the recombinant expression of LTC4S, allowing for more detailed biochemical characterizations and structure-function analyses. This approach helps to uncover the enzyme's active sites, substrate interactions, and potential post-translational modifications that may influence its activity. Such investigations not only enhance our understanding of LTC4S's role in leukotriene biosynthesis but also pave the way for innovative therapeutic strategies aimed at mitigating the effects of excessive leukotriene production in inflammatory diseases.